Daclizumab versus anti-thymocyte globulin-fresenius as induction therapy for low-risk kidney transplant recipients.

MM Abou-Jaoude, I Ghantous, R Najm, C Afif, WY Almawi

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Original language	English
Title of host publication	Transplantation proceedings
Pages	2731
Number of pages	1
Volume	35
Publication status	Published - 2003

Cite this

@inproceedings{b85070b180ac4c579381ee48601ea7bc,

title = "Daclizumab versus anti-thymocyte globulin-fresenius as induction therapy for low-risk kidney transplant recipients.",

author = "MM Abou-Jaoude and I Ghantous and R Najm and C Afif and WY Almawi",

year = "2003",

language = "English",

volume = "35",

pages = "2731",

booktitle = "Transplantation proceedings",

}